Title:Regulation of Nanomaterials and Nanomedicines for Clinical Application
Volume: 10
Author(s): Razi Ahmed, Vikash Maurya, Anurag Dwivedi and Manoj Kumar Mishra*
Affiliation:
- Shambhunath Institute of Pharmacy, Jhalwa, Prayagraj, Uttar Pradesh, 211015, India
Keywords:
Nanoscale, nanoparticles, nanotechnology, heart disease, tumor, nanomedicine, genes.
Abstract: Treatment of complicated fatal diseases was difficult when nanotechnology was not
more popular. The incorporation of nanomedicine has increased in the last 13 years, even though
regulatory guidelines regarding nanomaterials and nanomedicine weren't sufficient. Hence, it
was tough to decide valid inevitability for the manufacturers, administrators, health professionals,
primary care providers, and rest of the public that could ultimately have a negative impact on
the financing system, research, and development of such items, affecting the approval of the public
and acceptance of nano-products. This review includes coverage across the therapeutic value
of nanomaterials, problems in the regulation, regulatory challenges, synthesis, physicochemical
properties, and clinical application. The hurdles to using nanotechnology, particularly in the
pharmaceutical development of novel medicinal products and respective regulatory issues, are
critically explored, considering the characteristics offered by the nanomaterials.